지루성 각화증 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)
Seborrheic Keratosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
상품코드:1706774
리서치사:Transparency Market Research
발행일:2025년 02월
페이지 정보:영문 202 Pages
라이선스 & 가격 (부가세 별도)
한글목차
지루성 각화증 치료제 시장 - 조사 범위
TMR의 보고서 "세계 지루성 각화증 치료제 시장"은 2025년부터 2035년까지의 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회도 조사했습니다. 이 보고서는 2019년부터 2035년까지의 세계 지루성 각화증 치료제 시장의 수익 및 예측을 제공하기 위해 2025년을 기준 연도로, 2035년을 예측 연도로 설정했습니다. 또한, 2025년부터 2035년까지 세계 지루성 각화증 치료제 시장의 연평균 성장률(CAGR %)을 제시합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참고하여 지루성 각화증 치료 시장을 이해하고자 했습니다.
시장 스냅샷
2024년 시장 규모
25억 달러
2035년 시장 규모
45억 달러
CAGR
5.8%
이 보고서는 세계 지루성 각화증 치료제 시장의 경쟁 환경을 조사하고 있습니다. 세계 지루성 각화증 치료제 시장에서 활동하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성별로 프로파일링되어 있습니다. 회사 개요, 재무 상태, 최근 동향, SWOT는 세계 지루성 각화증 치료제 시장 기업의 속성이며, 이 보고서에서 소개합니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
소개
개요
시장 역학
세계의 지루성 각화증 치료 시장 시장 분석과 예측, 2020-2035년
제5장 주요 인사이트
주요 업계 이벤트(파트너십, 협업, 합병, 인수 등)
지루성 각화증 개요
치료 알고리즘
질병 진단
Porter's Five Forces 분석
PESTEL 분석
주요 국가·지역별 규제 시나리오
밸류체인 분석
가격 동향
주요 경쟁이 제공하는 제품 벤치마크
신규 시장 진입자를 위한 시장 개척 전략
제6장 세계의 시장 분석과 예측 : 치료 종류별
소개와 정의
주요 조사 결과/진전
시장 금액 예측 치료 종류별, 2020-2035년
약리학적
40% 과산화수소
타자로틴 크림 0.1%
알파 하이드록시산(AHA)
비타민 D3 크림
비약리학적
냉동요법
전기소작술/소파술
피부 박리
레이저 요법
기타(국소 케미컬 필링, 면도 절제 등)
치료 종류별 시장 매력
제7장 세계의 시장 분석과 예측 : 적응증별
소개와 정의
주요 조사 결과/진전
시장 금액 예측 : 적응증별, 2020-2035년
망상 지루성 각화증
멜라닌극세포종
클론성 지루성 각화증
염증성 지루성 각화증
기타
적응증별 시장 매력
제8장 세계의 시장 분석과 예측 : 치료 가용성별
소개와 정의
주요 조사 결과/진전
시장 금액 예측 치료 가용성별, 2020-2035년
약리학적
병원 약국
소매 약국
온라인 약국
비약리학적
병원
피부과 클리닉
기타(수술 센터 등)
치료 가용성별 시장 매력
제9장 세계의 시장 분석과 예측 : 지역별
주요 조사 결과
시장 금액 예측 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
국가·지역별 시장 매력
제10장 북미의 시장 분석과 예측
미국
캐나다
제11장 유럽의 시장 분석과 예측
독일
영국
프랑스
이탈리아
스페인
기타 유럽
제12장 아시아태평양의 시장 분석과 예측
중국
일본
인도
호주와 뉴질랜드
기타 아시아태평양
제13장 라틴아메리카의 시장 분석과 예측
브라질
멕시코
기타 라틴아메리카
제14장 중동 및 아프리카의 시장 분석과 예측
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
제15장 경쟁 구도
시장 기업 - 경쟁 매트릭스(기업 계층별·규모별)
시장 점유율 분석 기업별(2024년)
기업 개요
Aclaris Therapeutics, Inc.
Quanta System, S.p.A.
BioLight Technologies LLC.
AngioDynamics
Alma Lasers
Becton Dickinson and Company
Erchonia Corporation
IRIDEX Corp
Cutera
Biolase Inc
Cosette Pharmaceuticals
Lumenis
Mayne Pharma Group Limited
Fermenta Biotech
Brenntag Nordic A/S
Other Prominent Players
ksm
영문 목차
영문목차
Seborrheic Keratosis Treatment Market - Scope of Report
TMR's report on the global seborrheic keratosis treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global seborrheic keratosis treatment market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global seborrheic keratosis treatment market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the seborrheic keratosis treatment market.
Market Snapshot
Market Value in 2024
US$ 2.5 Bn
Market Value in 2035
US$ 4.5 Bn
CAGR
5.8%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global seborrheic keratosis treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global seborrheic keratosis treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global seborrheic keratosis treatment market.
The report delves into the competitive landscape of the global seborrheic keratosis treatment market. Key players operating in the global seborrheic keratosis treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global seborrheic keratosis treatment market profiled in this report.
Key Questions Answered in Global seborrheic keratosis treatment Market Report:
What is the sales/revenue generated by seborrheic keratosis treatment across all regions during the forecast period?
What are the opportunities in the global seborrheic keratosis treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2035?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Seborrheic Keratosis Treatment Market - Research Objectives and Research Approach
The comprehensive report on the global seborrheic keratosis treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global seborrheic keratosis treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global seborrheic keratosis treatment market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Seborrheic Keratosis Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Seborrheic Keratosis Treatment Market Analysis and Forecasts, 2020-2035
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events (Partnerships, Collaborations, Mergers, Acquisitions, etc.)
5.2. Overview on Seborrheic Keratosis
5.3. Treatment Algorithm
5.4. Disease Diagnosis
5.5. PORTER's Five Forces Analysis
5.6. PESTLE Analysis
5.7. Regulatory Scenario by Key Countries/Regions
5.8. Value Chain Analysis
5.9. Pricing Trends
5.10. Benchmarking of the Products Offered by the Leading Competitors
5.11. Go-to-Market Strategy for New Market Entrants
6. Global Seborrheic Keratosis Treatment Market Analysis and Forecasts, By Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Treatment Type, 2020-2035
6.3.1. Pharmacological
6.3.1.1. 40% Hydrogen Peroxide
6.3.1.2. Tazarotene cream 0.1%
6.3.1.3. Alpha Hydroxy Acid (AHA)
6.3.1.4. Vitamin D3 cream
6.3.2. Non-Pharmacological
6.3.2.1. Cryotherapy
6.3.2.2. Electrodessication/Curettage
6.3.2.3. Dermabrasion
6.3.2.4. Laser Therapy
6.3.2.5. Others (Focal Chemical Peel, Shave Excision, etc.)
6.4. Market Attractiveness By Treatment Type
7. Global Seborrheic Keratosis Treatment Market Analysis and Forecasts, By Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Indication, 2020-2035
7.3.1. Reticulated Seborrheic Keratosis
7.3.2. Melanoacanthoma
7.3.3. Clonal Seborrheic Keratosis
7.3.4. Irritated Seborrheic Keratosis
7.3.5. Others
7.4. Market Attractiveness By Indication
8. Global Seborrheic Keratosis Treatment Market Analysis and Forecasts, By Treatment Availability
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Treatment Availability, 2020-2035
8.3.1. Pharmacological
8.3.1.1. Hospital Pharmacy
8.3.1.2. Retail Pharmacy
8.3.1.3. Online Pharmacy
8.3.2. Non-Pharmacological
8.3.2.1. Hospitals
8.3.2.2. Dermatology Clinics
8.3.2.3. Others (Surgery Centers, etc.)
8.4. Market Attractiveness By Treatment Availability
9. Global Seborrheic Keratosis Treatment Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Seborrheic Keratosis Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Treatment Type, 2020-2035
10.2.1. Pharmacological
10.2.1.1. 40% Hydrogen Peroxide
10.2.1.2. Tazarotene cream 0.1%
10.2.1.3. Alpha Hydroxy Acid (AHA)
10.2.1.4. Vitamin D3 cream
10.2.2. Non-Pharmacological
10.2.2.1. Cryotherapy
10.2.2.2. Electrodessication/Curettage
10.2.2.3. Dermabrasion
10.2.2.4. Laser Therapy
10.2.2.5. Others (Focal Chemical Peel, Shave Excision, etc.)
10.3. Market Value Forecast By Indication, 2020-2035
10.3.1. Reticulated Seborrheic Keratosis
10.3.2. Melanoacanthoma
10.3.3. Clonal Seborrheic Keratosis
10.3.4. Irritated Seborrheic Keratosis
10.3.5. Others
10.4. Market Value Forecast By Treatment Availability, 2020-2035
10.4.1. Pharmacological
10.4.1.1. Hospital Pharmacy
10.4.1.2. Retail Pharmacy
10.4.1.3. Online Pharmacy
10.4.2. Non-Pharmacological
10.4.2.1. Hospitals
10.4.2.2. Dermatology Clinics
10.4.2.3. Others (Surgery Centers, etc.)
10.5. Market Value Forecast By Country, 2020-2035
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment Type
10.6.2. By Indication
10.6.3. By Treatment Availability
10.6.4. By Country
11. Europe Seborrheic Keratosis Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Treatment Type, 2020-2035
11.2.1. Pharmacological
11.2.1.1. 40% Hydrogen Peroxide
11.2.1.2. Tazarotene cream 0.1%
11.2.1.3. Alpha Hydroxy Acid (AHA)
11.2.1.4. Vitamin D3 cream
11.2.2. Non-Pharmacological
11.2.2.1. Cryotherapy
11.2.2.2. Electrodessication/Curettage
11.2.2.3. Dermabrasion
11.2.2.4. Laser Therapy
11.2.2.5. Others (Focal Chemical Peel, Shave Excision, etc.)
11.3. Market Value Forecast By Indication, 2020-2035
11.3.1. Reticulated Seborrheic Keratosis
11.3.2. Melanoacanthoma
11.3.3. Clonal Seborrheic Keratosis
11.3.4. Irritated Seborrheic Keratosis
11.3.5. Others
11.4. Market Value Forecast By Treatment Availability, 2020-2035
11.4.1. Pharmacological
11.4.1.1. Hospital Pharmacy
11.4.1.2. Retail Pharmacy
11.4.1.3. Online Pharmacy
11.4.2. Non-Pharmacological
11.4.2.1. Hospitals
11.4.2.2. Dermatology Clinics
11.4.2.3. Others (Surgery Centers, etc.)
11.5. Market Value Forecast By Country/Sub-region, 2020-2035
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Treatment Type
11.6.2. By Indication
11.6.3. By Treatment Availability
11.6.4. By Country/Sub-region
12. Asia Pacific Seborrheic Keratosis Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Treatment Type, 2020-2035
12.2.1. Pharmacological
12.2.1.1. 40% Hydrogen Peroxide
12.2.1.2. Tazarotene cream 0.1%
12.2.1.3. Alpha Hydroxy Acid (AHA)
12.2.1.4. Vitamin D3 cream
12.2.2. Non-Pharmacological
12.2.2.1. Cryotherapy
12.2.2.2. Electrodessication/Curettage
12.2.2.3. Dermabrasion
12.2.2.4. Laser Therapy
12.2.2.5. Others (Focal Chemical Peel, Shave Excision, etc.)
12.3. Market Value Forecast By Indication, 2020-2035
12.3.1. Reticulated Seborrheic Keratosis
12.3.2. Melanoacanthoma
12.3.3. Clonal Seborrheic Keratosis
12.3.4. Irritated Seborrheic Keratosis
12.3.5. Others
12.4. Market Value Forecast By Treatment Availability, 2020-2035
12.4.1. Pharmacological
12.4.1.1. Hospital Pharmacy
12.4.1.2. Retail Pharmacy
12.4.1.3. Online Pharmacy
12.4.2. Non-Pharmacological
12.4.2.1. Hospitals
12.4.2.2. Dermatology Clinics
12.4.2.3. Others (Surgery Centers, etc.)
12.5. Market Value Forecast By Country/Sub-region, 2020-2035
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Treatment Type
12.6.2. By Indication
12.6.3. By Treatment Availability
12.6.4. By Country/Sub-region
13. Latin America Seborrheic Keratosis Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Treatment Type, 2020-2035
13.2.1. Pharmacological
13.2.1.1. 40% Hydrogen Peroxide
13.2.1.2. Tazarotene cream 0.1%
13.2.1.3. Alpha Hydroxy Acid (AHA)
13.2.1.4. Vitamin D3 cream
13.2.2. Non-Pharmacological
13.2.2.1. Cryotherapy
13.2.2.2. Electrodessication/Curettage
13.2.2.3. Dermabrasion
13.2.2.4. Laser Therapy
13.2.2.5. Others (Focal Chemical Peel, Shave Excision, etc.)
13.3. Market Value Forecast By Indication, 2020-2035
13.3.1. Reticulated Seborrheic Keratosis
13.3.2. Melanoacanthoma
13.3.3. Clonal Seborrheic Keratosis
13.3.4. Irritated Seborrheic Keratosis
13.3.5. Others
13.4. Market Value Forecast By Treatment Availability, 2020-2035
13.4.1. Pharmacological
13.4.1.1. Hospital Pharmacy
13.4.1.2. Retail Pharmacy
13.4.1.3. Online Pharmacy
13.4.2. Non-Pharmacological
13.4.2.1. Hospitals
13.4.2.2. Dermatology Clinics
13.4.2.3. Others (Surgery Centers, etc.)
13.5. Market Value Forecast By Country/Sub-region, 2020-2035
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Treatment Type
13.6.2. By Indication
13.6.3. By Treatment Availability
13.6.4. By Country/Sub-region
14. Middle East & Africa Seborrheic Keratosis Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Treatment Type, 2020-2035
14.2.1. Pharmacological
14.2.1.1. 40% Hydrogen Peroxide
14.2.1.2. Tazarotene cream 0.1%.
14.2.1.3. Alpha Hydroxy Acid (AHA)
14.2.1.4. Vitamin D3 cream
14.2.2. Non-Pharmacological
14.2.2.1. Cryotherapy
14.2.2.2. Electrodessication/Curettage
14.2.2.3. Dermabrasion
14.2.2.4. Laser Therapy
14.2.2.5. Others (Focal Chemical Peel, Shave Excision, etc.)
14.3. Market Value Forecast By Indication, 2020-2035
14.3.1. Reticulated Seborrheic Keratosis
14.3.2. Melanoacanthoma
14.3.3. Clonal Seborrheic Keratosis
14.3.4. Irritated Seborrheic Keratosis
14.3.5. Others
14.4. Market Value Forecast By Treatment Availability, 2020-2035
14.4.1. Pharmacological
14.4.1.1. Hospital Pharmacy
14.4.1.2. Retail Pharmacy
14.4.1.3. Online Pharmacy
14.4.2. Non-Pharmacological
14.4.2.1. Hospitals
14.4.2.2. Dermatology Clinics
14.4.2.3. Others (Surgery Centers, etc.)
14.5. Market Value Forecast By Country/Sub-region, 2020-2035
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Treatment Type
14.6.2. By Indication
14.6.3. By Treatment Availability
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
